Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
doi: 10.1186/s12887-022-03671-x 9 SharmaMMcFarlaneCKambadurRKukretiHBonalaSSrinivasanS
The primary outcome was pain intensity after 4 months of treatment
Appendix E
The expanded approval was based on data from the Phase III EoE KIDS trial, where 66% of children who received the higher dose Dupixent at tiered dosing regimens experienced histological disease remission after 16 weeks of treatment, compared to just 3% in the placebo group, per the press release
US$ 20.94
US$ 28.51
US$ 29.27
US$ 26.30
US$ 26.20
